VEGF Polymorphism Analysis
Test Code
16959
81479
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Clinical Significance
VEGF Polymorphism Analysis - This genotyping test provides information on the genetic background of patients who already have cancer. Different genotypes have been reported to correlate with response or side-effects to certain medications.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
SNaPshot
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
See Laboratory Report
Preferred Specimen(s)
5 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
2 mL
Transport Container
EDTA (lavender-top) tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 8 days
- Refrigerated: 14 days
- Frozen: Unacceptable
Reject Criteria
Gross hemolysis • Received frozen • Clotted • Formalin-fixed paraffin embedded tissue • FFPE: All baked slides
Setup Schedule
5 mL whole blood collected in an EDTA (lavender-top) tube
2 mL
EDTA (lavender-top) tube
Room temperature
Room temperature: 8 days
Refrigerated: 14 days
Frozen: Unacceptable
Refrigerated: 14 days
Frozen: Unacceptable
Gross hemolysis • Received frozen • Clotted • Formalin-fixed paraffin embedded tissue • FFPE: All baked slides